Psychiatry and Neurology, Neurology · New Orleans, LA
NPI
1427169283
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2820 Napoleon Ave, Suite 700
New Orleans, LA, 70115
Phone (504) 412-1517
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
112 services
Medicare patients, 2024
55
Average age 74
Drug cost, 2024
$1.4M
406 prescriptions
Company payments, 2025
$46K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John D England was code 99214 (office e&m - established), 34 times for 25 patients. In total John D England billed 112 services in 14 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 34 | 25 | $87.18 | $2,964 |
| 99205 Office E&M - New | Office | 13 | 13 | $155.99 | $2,028 |
| 99215 Office E&M - Established | Office | 12 | 12 | $117.77 | $1,413 |
By year: 2022 $17K for 152 services; 2023 $13K for 138 services; 2024 $10K for 112 services.
Medicare prescription drug claims, 2024
In 2024, the drug John D England prescribed most often to Medicare patients was Gabapentin, with 71 prescriptions and refills. In total John D England wrote 406 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 71 | 93 | 15 | $1,667 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 56 | 56 | Under 11 | $436K |
| Prednisone Generic | 42 | 114 | Under 11 | $222 |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 41 | 41 | Under 11 | $288K |
| Pregabalin Generic | 40 | 40 | Under 11 | $873 |
| Mycophenolate Mofetil Generic | 34 | 46 | Under 11 | $2,636 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 24 | 24 | Under 11 | $305K |
| Gralise Gabapentin | 17 | 17 | Under 11 | $11K |
| Duloxetine Hcl Generic | 16 | 24 | Under 11 | $172 |
Brand drugs: 150 claims; generic drugs: 256 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John D England $46K ($46K in general payments such as food, travel and fees) from 17 companies. The largest payer was Argenx US, Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 31 | $25K |
| Grifols USA, LLC | 13 | $9,946 |
| Grifols Shared Services North America, Inc. | 18 | $8,640 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $1,640 |
| Amgen Inc. AMGN | 5 | $161 |
| UCB, Inc. UCB.BR | 1 | $116 |
| Neurelis, Inc. | 4 | $104 |
| Biogen, Inc. BIIB | 4 | $81.76 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $72.83 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $44.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.